| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (tet(M)) |
- |
- |
0.25 － ? |
Tigecycline (GAR-936, Tigacyl)  |
322 |
| Staphylococcus aureus (tet(M)) |
- |
- |
2 － ? |
Tigecycline (GAR-936, Tigacyl) |
47 |
| Staphylococcus aureus (tet(M)) |
- |
- |
64 － ? |
Minocycline (Minocycline hydrochloride, Minocin) |
47 |
| Staphylococcus aureus (tetracycline-susceptible) |
- |
- |
2 － ? |
Minocycline (Minocycline hydrochloride, Minocin) |
47 |
| Staphylococcus aureus (tobramycin-intermediate) |
- |
- |
8 － ? |
Tobramycin (Tobrex, Nebcin) |
452 |
| Staphylococcus aureus (tobramycin-resistant) |
- |
- |
≥16 － ? |
Tobramycin (Tobrex, Nebcin) |
452 |
| Staphylococcus aureus (tobramycin-susceptible) |
- |
- |
≤4 － ? |
Tobramycin (Tobrex, Nebcin) |
452 |
| Staphylococcus aureus (TP + oxacillin-resistant) |
- |
- |
0.25 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
220 |
| Staphylococcus aureus (TP + oxacillin-resistant) |
- |
- |
4 － ? |
Ampicillin (Omnipen) |
220 |
| Staphylococcus aureus (TP + oxacillin-susceptible) |
- |
- |
0.25 － ? |
Ampicillin (Omnipen) |
220 |
| Staphylococcus aureus (TP + oxacillin-susceptible) |
- |
- |
0.5 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
220 |
| Staphylococcus aureus (Trazié + methicillin-resistant) |
- |
- |
? － 0.8 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
68 |
| Staphylococcus aureus (Trazié + methicillin-resistant) |
- |
- |
? － >50 |
Gentamicin (Gentamycin, Garamycin) |
68 |
| Staphylococcus aureus (trimethoprim-resistant) |
- |
- |
≥16 － ? |
Trimethoprim (Proloprim, Trimpex) |
452 |
| Staphylococcus aureus (trimethoprim-susceptible) |
- |
- |
≤8 － ? |
Trimethoprim (Proloprim, Trimpex) |
452 |
| Staphylococcus aureus (U271) |
- |
- |
<0.125 － ? |
Gentamicin (Gentamycin, Garamycin) |
1450 |
| Staphylococcus aureus (U271) |
- |
- |
5000 － ? |
Campylospermum densiflorum leaf (Crude extract) |
1450 |
| Staphylococcus aureus (U949) |
- |
- |
125 － ? |
EtBr/Reserpine |
1033 |
| Staphylococcus aureus (U949) |
- |
- |
250 － ? |
Ethidium bromide (EtBr) |
1033 |
| Staphylococcus aureus (U949) |
- |
- |
5000 － ? |
Reserpine |
1033 |
| Staphylococcus aureus (UC12084 + methicillin-resistant) |
- |
- |
1 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
240 |
| Staphylococcus aureus (UC12084 + methicillin-resistant) |
- |
- |
2 － ? |
Vancomycin (Vancocyn, Lyphocin) |
240 |
| Staphylococcus aureus (UC15082 + methicillin-resistant) |
- |
1 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
240 |
| Staphylococcus aureus (UC15082 + methicillin-resistant) |
- |
- |
4 － ? |
Eperezolid (PNU-100592) |
240 |
| Staphylococcus aureus (UC15082 + methicillin-resistant) |
- |
- |
4 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
240 |
| Staphylococcus aureus (UC15083 + multidrug-resistant) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
240 |
| Staphylococcus aureus (UC15083 + multidrug-resistant) |
- |
- |
4 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
240 |
| Staphylococcus aureus (UC15084 + multidrug-resistant) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
240 |